We focused particularly on STAT3, which has been demonstrated to be a key regulator of glucose metabolism in HCC (Li et al., 2017; Liu and Yu, 2018; Wang et al., 2012). The gene discussed is STAT3; the disease is hepatocellular carcinoma.